B

BiohacksAI

Evidence-Based Biohacking

Patent Pending

THYROID

MOLECULAR TARGET

thyroid stimulating hormone receptor (human)

UniProt: P1647317 compounds

THYROID (thyroid stimulating hormone receptor (human)) is targeted by 17 compounds in the BiohacksAI evidence corpus, derived from PubMed bioassay data. Each compound is ranked by confidence score (log-normalized assay count × evidence quality).

Compounds Targeting THYROID

Ranked by bioassay confidence score (PubChem active assay count × evidence quality).

#CompoundConfidenceActive Assays
1Niclosamide1.102
2Triiodothyronine1.102
3Cilostazol0.691
4Clotrimazole0.691
5deguelin [Supplementary Concept]0.691
6Dinoprostone0.691
7Carbonyl Cyanide p-Trifluoromethoxyphenylhydrazone0.691
8Hexachlorophene0.691
9Levalbuterol0.691
10lonidamine0.691
11Loratadine0.691
12Maprotiline0.691
13Piperonyl Butoxide0.691
14Sulfisoxazole0.691
15Testosterone Propionate0.691
16Toxaphene0.691
17tyrphostin 90.691

About THYROID as a Drug Target

THYROID (thyroid stimulating hormone receptor (human)) is a well-characterized molecular target in biomedical research. BiohacksAI tracks 17 compounds with documented THYROID interaction from PubChem bioassay data, cross-referenced with PubMed clinical evidence. The confidence score reflects the log-normalized count of active PubChem assays, weighted by evidence quality from the BiohacksAI corpus.

THYROID inhibitors, activators, and modulators are of interest in research areas including longevity, metabolic health, and neurological function. Each compound profile includes evidence score, RCT count, human study ratio, research velocity, and domain relevance.